none title certification

UAB "Tolifarma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data
Financial report background

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
320
320
23,524
-23,524
-23,524
-7,520.31
-7,351.25
66,130
258
41,358
25,030
2023
6,800
6,800
30,217
-30,217
-30,217
-443.91
-444.37
35,913
219
30,009
6,123
2024
1,180
1,180
15,609
-15,609
-15,609
-1,949.75
-1,322.80
20,304
382
9,722
10,964
unlock data icon

Register and

explore Okredo data
2024
1,180
1,180
15,609
-15,609
-15,609
-1,949.75
-1,322.80
20,304
382
9,722
10,964
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

1,180 €Descended-83 % *

Sales per employee (€)

1,180 €Descended-83 % *

Profit before tax (€)

15,609 €Descended-48 % *

Net Profit (€)

-15,609 €Ascended48 % *

Profit per employee (€)

-15,609 €Ascended48 % *

Total profitability (%)

-1,949.75 %Descended-339.22 % *

Net profitability (%)

-1,322.80 %Descended-197.68 % *

Equity (€)

20,304 €Descended-43 % *

Amounts Payable And Liabilities (€)

382 €Ascended74 % *

Non-current Assets (€)

9,722 €Descended-68 % *

CurrentAssets (€)

10,964 €Ascended79 % *

*over the last year starting selected period